🇺🇸 FDA
Patent

US 9226970

Oligomer modified diaromatic substituted compounds

granted A61KA61K31/496A61K47/60

Quick answer

US patent 9226970 (Oligomer modified diaromatic substituted compounds) held by Nektar Therapeutics expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/496, A61K47/60, A61P, A61P31/18